Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS

GLIA

Volumn 55, Issue 7, 2007, Pages 687-697

  Vana, Adam C ^a   Lucchinetti, Claudia F ^b   Le, Tuan Q ^a   Armstrong, Regina C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Multiple sclerosis; Myelin; Oligodendrocyte progenitor; Oligodendroglia; Remyelination

Indexed keywords

ANTIGEN; ANTIGEN CC1; DNA BINDING PROTEIN; MYELIN TRANSCRIPTION FACTOR 1; PHOSPHATE BUFFERED SALINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN MUSASHI1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DENSITY; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPHOCYTE; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REMYELINIZATION; SPINAL CORD DISEASE; STEM CELL; VIRUS STRAIN; WHITE MATTER;

ADULT; ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS; FEMALE; HUMANS; MICE; MULTIPLE SCLEROSIS; MURINE HEPATITIS VIRUS; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA; RECOVERY OF FUNCTION; SPINAL CORD; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 34247525883     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20492     Document Type: Article

References (42)

1. Armstrong RC. 2000. Potential roles of trophic factors in CNS development and recovery from demyelinating disease. In: Mocchetti I, editor. Neurotrophic factors. Graham Publishing, Mountain Home, TN. pp 417-437.
2. Armstrong RC, Kim JG, Hudson LD. 1995. Expression of myelin transcription factor I (MyTI), a "zinc-finger" DNA-binding protein, in developing oligodendrocytes. Glia 14:303-321.
3. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC. 2002. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574-8585.
4. Armstrong RC, Migneault A, Shegog ML, Kim JG, Hudson LD, Hessler RB. 1997. High-grade human brain tumors exhibit increased expression of myelin transcription factor 1 (MYT1), a zinc finger DNA-binding protein. J Neuropathol Exp Neurol 56:772-781.
5. Armstrong RC, Redwine JM, Messersmith DJ. 2005. Coronavirus-induced demyelination and spontaneous remyelination: Growth factor expression and function. In: Lavi E, Constantinescu CS, editors. Experimental models of multiple sclerosis. Norwell, MA: Springer Science. p 2005.
6. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD. 2004. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111-2115.
7. Bruck W, Kuhlmann T, Stadelmann C. 2003. Remyelination in multiple sclerosis. J Neurol Sci 206:181-185.
8. Bruck W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H. 1995. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38:788-796.
9. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
10. Fancy SP, Zhao C, Franklin RJ. 2004. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27:247-254.
11. Ferguson B, Matyszak MK, Esiri MM, Perry VH. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120(Part 3):393-399.
12. Franklin RJ, Gilson JM, Blakemore WF. 1997. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J Neurosci Res 50:337-344.
13. Frost EE, Nielsen JA, Le TQ, Armstrong RC. 2003. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J Neurobiol 54:457-472.
14. Gensert JM, Goldman JE. 1997. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19:197-203.
15. Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq. 1989. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol 109:2405-2416.
16. Gokhan S, Marin-Husstege M, Yung SY, Fontanez D, Casaccia-Bonnefil P, Mehler MF. 2005. Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. J Neurosci 25:8311-8321.
17. Hirayama A, Oka A, Ito M, Tanaka F, Okoshi Y, Takashima S. 2003. Myelin transcription factor 1 (MyT1) immunoreactivity in infants with periventricular leukomalacia. Brain Res Dev Brain Res 140:85-92.
18. Hudson LD, Berndt JA, Puckett C, Kozak CA, Lazzarini RA. 1987. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc Natl Acad Sci USA 84:1454-1458.
19. Kaneko Y, Sakakibara S, Imai T, Suzuki A, Nakamura Y, Sawamoto K, Ogawa Y, Toyama Y, Miyata T, Okano H. 2000. Musashi1: An evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22:139-153.
20. Kim JG, Armstrong RC, Berndt JA, Kim NW, Hudson LD. 1998. A secreted DNA-binding protein that is translated through an internal ribosome entry site (IRES) and distributed in a discrete pattern in the central nervous system. Mol Cell Neurosci 12:119-140.
21. Kim JG, Armstrong RC, v Agoston D, Robinsky A, Wiese C, Nagle J, Hudson LD. 1997. Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system. J Neurosci Res 50:272-290.
22. Kim JG, Hudson LD. 1992. Novel member of the zinc finger superfamily: A C2-HC finger that recognizes a glia-specific gene. Mol Cell Biol 12:5632-5639.
23. Koyano-Nakagawa N, Wettstein D, Kintner C. 1999. Activation of Xenopus genes required for lateral inhibition and neuronal differentiation during primary neurogenesis. Mol Cell Neurosci 14:327-339.
24. Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD, Rowitch DH. 2006. Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci USA 103:7853-7858.
25. Lucchinetti CF, Parisi J, Bruck W. 2005. The pathology of multiple sclerosis. Neurol Clin 23:77-105.
26. Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P. 2001. Platelet-derived growth factor-α receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol 49:776-785.
27. Matthews AE, Weiss SR, Paterson Y. 2002. Murine hepatitis virus-a model for virus-induced CNS demyelination. J Neurovirol 8:76-85.
28. Morales Y, Parisi JE, Lucchinetti CF. 2006. The pathology of multiple sclerosis: Evidence for heterogeneity. Adv Neurol 98:27-45.
29. Nielsen JA, Berndt JA, Hudson LD, Armstrong RC. 2004. Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells. Mol Cell Neurosci 25:111-123.
30. Pincus DW, Keyoung HM, Harrison-Restelli C, Goodman RR, Fraser RA, Edgar M, Sakakibara S, Okano H, Nedergaard M, Goldman SA. 1998. Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells. Ann Neurol 43:576-585.
31. Redwine JM, Armstrong RC. 1998. In vivo proliferation of oligodendrocyte progenitors expressing PDGFαR during early remyelination. J Neurobiol 37:413-428.
32. Reynolds R, Cenci di Bello I, Dawson M, Levine J. 2001. The response of adult oligodendrocyte progenitors to demyelination in EAE. Prog Brain Res 132:165-174.
33. Romm E, Nielsen JA, Kim JG, Hudson LD. 2005. Myt1 family recruits histone deacetylase to regulate neural transcription. J Neurochem 93:1444-1453.
34. Sakakibara S, Okano H. 1997. Expression of neural RNA-binding proteins in the postnatal CNS: Implications of their roles in neuronal and glial cell development. J Neurosci 17:8300-8312.
35. Schneider ML, Turner DL, Vetter ML. 2001. Notch signaling can inhibit Xath 5 function in the neural plate and developing retina. Mol Cell Neurosci 18:458-472.
36. Sim FJ, Zhao C, Pendens J, Franklin RJ. 2002. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22:2451-2459.
37. Solanky M, Maeda Y, Ming X, Husar W, Li W, Cook S, Dowling P. 2001. Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques. J Neurosci Res 65:308-317.
38. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
39. Watanabe M, Hadzic T, Nishiyama A. 2004. Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia 46:311-322.
40. Watanabe M, Toyama Y, Nishiyama A. 2002. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69:826-836.
41. Wong K, Armstrong RC, Gyure KA, Morrison AL, Rodriguez D, Matalon R, Johnson AB, Wollmann R, Gilbert E, Le TQ, Bradley CA, Crutchfield K, Schiffmann R. 2000. Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. Acta Neuropathol (Berl) 100:635-646.
42. Wrathall JR, Li W, Hudson LD. 1998. Myelin gene expression after experimental contusive spinal cord injury. J Neurosci 18:8780-8793.